We are your one-stop shop for preclinical drug discovery and development services. We can accelerate your drug discovery and development projects. At IRBM, science comes first.
At IRBM, our experience in the development of custom assays is leveraged into a robust, efficient and multi-parameter validation platform to confirm the biological and pathological role of your novel target.
We recognize the challenges inherent in identifying the most promising hit for your target. Our team can deploy high-throughput screening technology on a 400,000-compound library.
Once our team has identified promising hits through a comprehensive screening campaign, we assess the hit series to evaluate their potential and select the most attractive for optimization.
At this stage, our chemists and biologists focus on improving the profile of the selected leads until it matches the target candidate profile agreed upon with our partners.
November 5-7, 2018 Copenhagen, Denmark Come meet ...
18 April 2018
June 4-7, 2018 Boston, MA, United States ...
6 April 2018
WASHINGTON, D.C., August 20, 2017 – At ...
20 August 2017
MILAN, June 20, 2017 – IRBM announced ...
20 June 2017
IRBM Science Park SpA
Via Pontina km 30,600
00071 Pomezia (RM), Italy